Scientific Workshop:
Menopausal Hormone Therapy
October 23-24, 2002
The workshop may be viewed at http://videocast.nih.gov (look under Past Events).
The purpose of this National Institutes of Health (NIH) conference was to review the results from the arm of the Women's Health Initiative (WHI) clinical trial studying combination estrogen and progestin that was recently stopped, to place them in the context of other completed and ongoing Federally funded research on menopausal combination hormone therapy (HT), and to help clinicians and patients understand the implications of current knowledge on decisions regarding short- and long-term use of HT. In addition, the most recent information from the U.S. Preventative Services Task Force on hormone therapy and chronic disease was presented as were recommendations on specific clinical uses of HT from other professional organizations. The conference provided information about alternatives for HT for treatment of specific conditions such as osteoporosis, heart disease, and vasomotor symptoms that include mood and sleep disorders. Other ongoing studies were reviewed.
Statement by Elias A. Zerhouni, M.D., Director, National Institutes of Health
To view a speaker's slide presentation (PowerPoint format) from the workshop, click on the name of the speaker below.
- Janet D. Allan, Ph.D., R.N., C.S., F.A.A.N. University of Maryland, Baltimore
- Rowan T. Chlebowski, M.D., Ph.D., Harbor-UCLA Research and Education Institute
- Ginger Constantine, M.D., Wyeth Pharmaceuticals
- Susan Dentzer, The News Hour with Jim Lehrer on PBS
- Lorraine Anne Fitzpatrick, M.D, Mayo Clinic and Foundation
- David Gordon, M.D., Ph.D., Division of Heart and Vascular Diseases, NHLBI
- Susan L. Hendrix, D.O., Wayne State University School of Medicine
- Richard J. Hodes, M.D., Director, NIA
- Rebecca D. Jackson, M.D., The Ohio State University
- Stephen Katz, M.D., Director, NIAMS
- Benita S. Katzenellenbogen, Ph.D., University of Illinois, Urbana
- Claude Lenfant, M.D., Director, NHLBI
- Marian C. Limacher, M.D., University of Florida College of Medicine
- James Liu, Fellow, American College of Obstetricians & Gynecologists
- Susan Love, M.D., Susan Love M.D. Breast Cancer Foundation
- Joan McGowan, Ph.D., Chief, Musculoskeletal Diseases Branch, NIAMS
- Heidi Nelson, M.D., M.P.H., Oregon Health and Science University
- Annette O'Connor, R.N., Ph.D., University of Toronto
- Pam Ouyang, M.D., American Heart Association
- Diana B. Petitti, M.D., Kaiser Permanente Southern California
- Vivian W. Pinn, M.D., Associate Director for Research on Women s Health; Director, Office of Research on Women's Health
- Clifford Rosen, President, American Society for Bone & Mineral Research
- Jacques Rossouw, M.D., NHLBI; Acting Director, WHI
- Judy Salerno, M.D., M.S., Deputy Director, NIA
- Peter Schmidt, M.D., Chief, Unit on Reproductive Endocrinology, NIMH
- Sally A. Shumaker, Ph.D., Wake Forest University
- Lisa A. Simpson, M.D., M.B., B.CH., F.A.A.P., Deputy Director, Agency for Healthcare Research and Quality
- Marcia L. Stefanick, Ph.D., Stanford University
- Stephen E. Straus, M.D., Director, NCCAM
- Wulf Utian, M.D., Executive Director, North American Menopause Society
- Andrew C. von Eschenbach, M.D., Director, NCI
- Robert W. Wallace, M.D., The University of Iowa
- Janet Woodcock, M.D., Director, CDER, FDA
- Barbara Yawn, M.D., MSc American Academy of Family Physicians
Final Agenda
Selected Articles Related to Menopausal Hormone Therapy (2000 - 2002)
Selected Articles Related to Menopausal Hormone Therapy (1981 - 1999)
Menopause Management and Hormone Therapy page
Annals of Internal Medicine